All In Biotech

Drug Trial Radar · NCT05895786

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS)

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 318 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

318

Planned (sponsor's estimate)

Start

May 20, 2023

Primary completion

Jul 29, 2030

Study completion Jul 29, 2030

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jun 9, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to understand how the study medicine PF-06823859 (dazukibart) works in people with idiopathic inflammatory myopathies (DM and PM). These disorders cause inflammation that weakens the muscles that are important for movement and may also cause skin rash in people with DM. This study is seeking participants who: * Are 18 years of age or older or minimum legal adult age as defined per local regulation, whichever is greater * Have active DM or active PM. * Are receiving a stable dose of 1 corticosteroid taken by mouth and/or 1 traditional immunosuppressant. * Note: Corticosteroids and immunosuppressants are medicines that help reduce inflammation and may signal to the immune system not to attack the body. Dermatomyositis (DM) is a rare disease that causes muscle inflammation that results in muscle weakness and low muscle stamina. Patients with DM have a characteristic skin rash. Polymyositis (PM) is a rare disease that involves mainly muscle inflammation resulting in muscle weakness, that can sometimes be painful. Patients with DM and PM may have trouble going up the steps, walking or getting to a standing position. Some of the participants will receive the study medicine (dazukibart) and some will receive placebo (which is similar to study medicine but contains no medicine in it). The study medicine or placebo will be given as an intravenous (IV) infusion (directly into the veins), which takes about 1 hour; every 4 weeks from Day 1 to Week 48 of the study. Both dazukibart and placebo and will be given at the study site. The study will compare the experiences of people receiving study medication to those of the people who do not. This will help to see if dazukibart is safe and effective. Participants will take part in this study for about 13 months. During this time, participants will have 15 study visits. These visits will be performed at the study site.

Conditions

  • Myositis

Interventions

  • PF-06823859Drug

    anti-interferon beta therapy

  • PlaceboDrug

    Placebo for PF-06823859

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Moderate change in Total Improvement Score (TIS)Time frame: 24 weeks outside of the United States (US) and 52 weeks in the US

Locations

138 sites in 20 countries. Site status is shown where the registry gives one.

  • Arizona Arthritis & Rheumatology Research, PLLC

    Glendale, Arizona · Recruiting

  • Neuromuscular Research Center

    Phoenix, Arizona · Recruiting

  • Mayo Clinic Hospital

    Phoenix, Arizona · Recruiting

  • Mayo Clinic in Arizona - Scottsdale

    Scottsdale, Arizona · Recruiting

  • 200 UCLA Medical Plaza

    Los Angeles, California · Recruiting

  • UCLA Clinical & Translational Research Center (CTRC)

    Los Angeles, California · Recruiting

  • UCLA

    Los Angeles, California · Recruiting

  • Center for Clinical Research - Chapman Pavilion

    Orange, California · Active not recruiting

  • UCI Douglas Hospital

    Orange, California · Active not recruiting

  • UCI Health Center for Innovative Health Therapies

    Orange, California · Active not recruiting

  • University of California - Irvine

    Orange, California · Active not recruiting

  • Samir Macwan, M.D., Inc.

    Rancho Mirage, California · Recruiting

  • Mayo Clinic in Florida

    Jacksonville, Florida · Recruiting

  • Lal Bhagchandani, M.D

    Margate, Florida · Active not recruiting

  • University of Miami

    Miami, Florida · Recruiting

  • University of Miami Dermatology Clinical Trials Unit

    Miami, Florida · Recruiting

  • University of Miami

    Miami, Florida · Recruiting

  • Unviversity of Miami

    Miami, Florida · Recruiting

  • Omega Research Orlando

    Orlando, Florida · Active not recruiting

  • IRIS Research and Development, LLC

    Plantation, Florida · Recruiting

  • West Broward Pulmonary Consultants

    Plantation, Florida · Recruiting

  • West Broward Rheumatology Associates

    Tamarac, Florida · Active not recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts · Recruiting

  • CTC - Brigham & Women's Hospital

    Boston, Massachusetts · Recruiting

  • CTH - Brigham & Women's Hospital

    Boston, Massachusetts · Recruiting

  • Washington University Pulmonary Function Laboratory

    St Louis, Missouri · Active not recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Active not recruiting

  • NYU Langone Health - Clinical and Translational Science Institute Research Pharmacy

    New York, New York · Recruiting

  • NYU Langone Health Clinical Research Center

    New York, New York · Recruiting

  • NYU Langone Health

    New York, New York · Recruiting

  • NYU Langone Radiology

    New York, New York · Recruiting

  • Hospital for Special Surgery - Belaire

    New York, New York · Not yet recruiting

  • Hospital for Special Surgery

    New York, New York · Not yet recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • RAO Research LLC

    Oklahoma City, Oklahoma · Recruiting

  • UPMC Arthritis and Autoimmunity Center, Falk Clinic

    Pittsburgh, Pennsylvania · Recruiting

  • UPMC Montefiore Clinical and Translational Research Center (CTRC)

    Pittsburgh, Pennsylvania · Recruiting

  • UPMC Presbyterian Shadyside Hospital

    Pittsburgh, Pennsylvania · Recruiting

  • Integrative Rheumatology of South Texas

    Edinburg, Texas · Recruiting

  • Arthritis & Rheumatology Research Institute, PLLC

    Frisco, Texas · Recruiting

Showing 40 of 138 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.